Navigation Links
Study Shows That Women Need To Be Explained About The Smear Test

A report in the British Journal of Cancer, explained that the women who receive abnormal smear test results need more reassurance that they are not necessarily on the brink of cancer, // More information is needed to help women understand their test results and ease their fears over cervical cancer. A study of more than 3500 women with slightly abnormal smears found that more than a quarter had unnecessarily high levels of anxiety.

Nicola Gray, of Aberdeen University's department of general practice and primary care and the study's lead author, said these results showed that those with slightly abnormal, or low-grade, smears suffered similar anxiety levels to women with high-grade smears. This she suggested was because women may not understand their test results or the meaning of the term pre-cancerous, and wrongly conclude that any abnormalities detected must indicate cancer. So she said that it was important to introduce strategies to improve women's understanding and to address their fears about cancer, treatment and fertility to help reduce this anxiety. She went on to explain that the women at highest risk of feeling anxious tended to be younger, have children, be smokers or had the highest levels of physical activity.

In this study, the women were screened for clinically significant anxiety using a scale known as the Hospital Anxiety and Depression Scale (Hads). On examining the scores the researchers found that 23% of the women were classified as probable cases of clinical anxiety and 20% of women as possible cases. These results they found were similar to those for women whose smears showed a higher degree of abnormality. The researchers said that this shows that there is not enough being done to inform women about what an abnormal smear means.

A slightly abnormal smear test indicates changes in the cells that could lead to cancer in the future but rarely does it mean that a woman already has cancer. In the majority of cases
'"/>




Page: 1 2

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
Other Medicine News:Health News:Command Medical Products, Inc. Welcomes James Carnall 2Health News:Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement 2Health News:Eating Disorder International Symposium - Shoreline Center for Eating Disorder Treatment and Eating Disorder Awareness Week, Converge on Solving the Life-Threatening Illness 2Health News:Eating Disorder International Symposium - Shoreline Center for Eating Disorder Treatment and Eating Disorder Awareness Week, Converge on Solving the Life-Threatening Illness 3Health News:Oridion Receives FDA 510(k) Clearance for Capnostream(TM)20 Monitor With Integrated Pulmonary Index(TM) 2Health News:Oridion Receives FDA 510(k) Clearance for Capnostream(TM)20 Monitor With Integrated Pulmonary Index(TM) 3Health News:Oridion Receives FDA 510(k) Clearance for Capnostream(TM)20 Monitor With Integrated Pulmonary Index(TM) 4Health News:The first Intervention About Women Compulsive Gamblers Airs on A&E February 23, 2009 at 9 PM: Williamsville Wellness will be Featured 2Health News:New clues to healing arthritis caused by traumatic injury 2Health News:New clues to healing arthritis caused by traumatic injury 3
Breaking Medicine Technology:AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Biochemical on switch could solve protein purification challenge 10485 1Biochemical on switch could solve protein purification challenge 10485 2Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 1Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 2Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 3Cocaine exposure during pregnancy leads to impulsivity in male not female monkeys 59955 4Flu shots not to be sneezed at 59952 1Flu shots not to be sneezed at 59952 2